|Articles|September 4, 2014
Antiprogestin CDB-2914 promising for uterine fibroids (VIDEO)
William Fredette, MD, discusses the benefits of Antiprogestin CDB-2914 for reducing uterine fibroid size and bleeding, and improving quality of life for affected women, as reported in the journal Fertility and Sterility. Video provided by The Doctor's Channel.
Advertisement
William Fredette, MD, discusses the benefits of Antiprogestin CDB-2914 for reducing uterine fibroid size and bleeding, and improving quality of life for affected women, as reported in the journal
This video is part of the
Video provided by:
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
GLP-1 RAs linked to broad menstrual adverse event signals in reproductive-aged patients
2
Biomarker testing for preeclampsia with Lisa A. Bukovac, DO, FACOG
3
Q+A: Connor Frey, MD, on GLP-1 RAs and menstrual adverse event signals
4
HIV screening, PrEP counseling get stronger ACOG recommendation
5